Sculptor Capital LP Has $73.41 Million Stock Position in Haleon plc (NYSE:HLN)

Sculptor Capital LP increased its stake in shares of Haleon plc (NYSE:HLN - Free Report) by 67.8% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,887,098 shares of the company's stock after buying an additional 3,592,000 shares during the quarter. Haleon comprises approximately 1.4% of Sculptor Capital LP's investment portfolio, making the stock its 18th biggest position. Sculptor Capital LP owned about 0.19% of Haleon worth $73,407,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. The Manufacturers Life Insurance Company increased its holdings in Haleon by 95.5% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,954,304 shares of the company's stock valued at $16,143,000 after buying an additional 954,622 shares during the period. Dimension Capital Management LLC boosted its position in shares of Haleon by 20.5% during the 2nd quarter. Dimension Capital Management LLC now owns 14,085 shares of the company's stock worth $116,000 after acquiring an additional 2,392 shares in the last quarter. Eminence Capital LP boosted its position in shares of Haleon by 8.0% during the 2nd quarter. Eminence Capital LP now owns 353,717 shares of the company's stock worth $2,922,000 after acquiring an additional 26,094 shares in the last quarter. Bank of Montreal Can increased its stake in Haleon by 10.4% in the second quarter. Bank of Montreal Can now owns 742,564 shares of the company's stock valued at $6,379,000 after acquiring an additional 69,939 shares during the last quarter. Finally, Altshuler Shaham Ltd acquired a new position in Haleon during the second quarter valued at approximately $1,348,000. Institutional investors own 6.67% of the company's stock.

Analyst Upgrades and Downgrades

HLN has been the topic of several recent analyst reports. Morgan Stanley lifted their price target on Haleon from $9.90 to $10.95 and gave the company an "overweight" rating in a research note on Friday, September 20th. The Goldman Sachs Group downgraded Haleon from a "buy" rating to a "neutral" rating in a research note on Tuesday, August 6th. Finally, Berenberg Bank began coverage on shares of Haleon in a report on Tuesday, August 6th. They issued a "buy" rating for the company. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $10.95.

Haleon Price Performance

Shares of NYSE HLN traded up $0.10 during mid-day trading on Friday, hitting $10.69. 3,162,286 shares of the stock traded hands, compared to its average volume of 4,921,797. Haleon plc has a twelve month low of $7.70 and a twelve month high of $10.80. The firm has a 50 day simple moving average of $9.91 and a two-hundred day simple moving average of $8.93. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58. The company has a market cap of $48.74 billion, a PE ratio of 35.30, a price-to-earnings-growth ratio of 3.12 and a beta of 0.26.

Haleon (NYSE:HLN - Get Free Report) last released its quarterly earnings data on Thursday, August 1st. The company reported $0.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.01). Haleon had a net margin of 9.71% and a return on equity of 13.15%. The firm had revenue of $3.50 billion during the quarter, compared to analyst estimates of $3.55 billion. During the same period in the prior year, the company earned $0.08 EPS. As a group, equities research analysts forecast that Haleon plc will post 0.47 EPS for the current fiscal year.

Haleon Cuts Dividend

The company also recently declared a semi-annual dividend, which was paid on Thursday, September 19th. Shareholders of record on Friday, August 16th were issued a dividend of $0.0514 per share. The ex-dividend date of this dividend was Friday, August 16th. This represents a yield of 1.6%. Haleon's payout ratio is 36.67%.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.